Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes by ethnicity and race: ONWARDS 1-5

被引：0
|
作者：
Lingvay, I. [1 ,2 ]
Bangsgaard, K. O. [3 ]
Desouza, C. [4 ]
Fragao-Marques, M. [3 ]
Navarria, A. [3 ]
Vianna, A. [5 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Sch Publ Hlth, Dallas, TX 75390 USA
[3] Novo Nordisk AS, Soborg, Denmark
[4] Univ Nebraska Med Ctr, Omaha, NE USA
[5] Hosp Nossa Senhora Gracas, Curitiba Diabet Ctr, Dept Endocrine Dis, Curitiba, Parana, Brazil
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
785
引用
收藏
页码：S375 / S376
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes by Ethnicity and Race-ONWARDS 1-5
    Lingvay, Ildiko
    Bangsgaard, Katrine O.
    Desouza, Cyrus
    Marques, Mariana Fragao
    Navarria, Andrea, Sr.
    Vianna, Andre G.
    DIABETES, 2024, 73
  • [2] Impact of age on the efficacy and safety of once-weekly insulin icodec vs once-daily insulin in type 2 diabetes: ONWARDS 1-5
    Vianna, A. G. D.
    Desouza, C.
    Laugesen, C.
    Fragao-Marques, M.
    Nielsen, P. H.
    Shaikh, S.
    Lingvay, I.
    DIABETOLOGIA, 2024, 67 : S376 - S376
  • [3] Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in individuals with type 2 diabetes by kidney function: ONWARDS 1-5
    Cheng, A. Y. Y.
    Rossing, P.
    Benamar, M.
    Laugesen, C.
    Nielsen, P. H.
    Bajaj, H. S.
    DIABETOLOGIA, 2024, 67 : S375 - S375
  • [4] Impact of Age on the Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Insulin in Type 2 Diabetes (ONWARDS 1-5)
    Vianna, Andre G. D.
    Desouza, Cyrus
    Laugesen, Christian
    Marques, Mariana Fragao
    Nielsen, Pernille Hojlund
    Shaikh, Shehla S.
    Lingvay, Ildiko
    DIABETES, 2024, 73
  • [5] Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Individuals with Type 2 Diabetes by Kidney Function-ONWARDS 1-5
    Rossing, Peter
    Benamar, Malik
    Cheng, Alice Y. Y.
    Laugesen, Christian
    Nielsen, Pernille Hojlund
    Bajaj, Harpreet S.
    DIABETES, 2024, 73
  • [6] Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6
    Russell-Jones, D.
    Babazono, T.
    Cailleteau, R.
    Engberg, S.
    Irace, C.
    Kjaersgaard, M. I. S.
    Mathieu, C.
    Rosenstock, J.
    Woo, V.
    Klonoff, D. C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S8
  • [7] No evidence of increased physical activity-related hypoglycaemia with once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes: ONWARDS 1-5
    Riddell, M. C.
    Heller, S.
    Asong, M.
    Carstensen, L.
    Watt, S. Kehlet
    Woo, V. C.
    DIABETOLOGIA, 2024, 67 : S376 - S377
  • [8] Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes according to baseline sodium-glucose cotransporter-2 inhibitor use: ONWARDS 1-5
    Goldenberg, R.
    Bangsgaard, K. O.
    Fu, A.
    Kellerer, M.
    Sogaard, S. B.
    Vilsboll, T.
    DIABETOLOGIA, 2024, 67 : S8 - S9
  • [9] No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes-ONWARDS 1-5
    Riddell, Michael C.
    Heller, Simon R.
    Asong, Marisse
    Carstensen, Lisbeth
    Watt, Sara K.
    Woo, Vincent C.
    DIABETES, 2024, 73
  • [10] The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1-5
    Riddell, Michael C.
    Heller, Simon
    Carstensen, Lisbeth
    Rocha, Thais M. Pagliaro
    Watt, Sara Kehlet
    Woo, Vincent C.
    DIABETOLOGIA, 2025,
12345